投資
10投資退出
4想告知投資者類似日本國債管理關於你的公司嗎?
提交你的分析師簡報在投資者麵前,CB Insights的平台上的客戶和合作夥伴。188bet游戏
最新的日本國債管理新聞
2023年5月16日
科羅拉多州丹佛市美國紐約,5月16日,2023(全球通訊社)——阿斯彭集團有限公司(“美國國際集團”)(場外粉紅色:ASPU),教育技術控股公司,今天宣布它已經關閉的私募債券與國債管理公司的總收入為1240萬美元,前11%的原始發行折扣,費用和其他融資費用,從高級擔保債券的發行。美國國際集團也發布了投資者220萬五年認股權證。公司打算使用私人配售所得償還現有債務和營運資本的目的。阿斯彭集團董事長兼首席執行官邁克爾•馬修斯說:“我們很高興宣布成功關閉這個融資與國債團隊,大大改善了阿斯彭集團的財務狀況。這將使我們能夠有效地管理時間的變化的金融援助現金流和償還我們出色的500萬美元的信用額度。我們繼續實現我們的目標,市場營銷是一個關鍵的催化劑,提高入學率在我們非常受歡迎的阿斯彭評審護理學位課程和一般大學MSN-FNP(家庭護士)學位課程,等等。以降低成本的實現可以改善我們的現金流操作,我們現在有機會增加我們公司營銷預算和位置調整後息稅前利潤繼續保持積極的。”The 36-month debentures, issued on May 11, 2023, bear interest at 15% per annum, are paid monthly, and are not convertible. The AGI’s obligations under the debentures are secured by substantially all of AGI’s and its subsidiaries’ assets. The debentures also contain customary affirmative and negative covenants, events of defaults and other customary terms for senior secured debentures. Each warrant entitles the holder to purchase one share of the company’s common stock at an exercise price of US $0.01 per share for five-years following the closing date of the offering. The company has filed its Quarterly Report on Form 10-Q for the three months ended January 31, 2023, with the Securities and Exchange Commission today, May 16, 2023. for further details on the terms and covenants related to this financing agreement, please refer to the footnote section in the 10-Q. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including the plan to increase marketing and continue to achieve positive Adjusted EBITDA. The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Important factors that could cause actual results to differ from those in the forward-looking statements include our ability to enroll new students and generate revenue from our new marketing program, the impact of a declining economy, inflation, higher interest rates, the banking crisis, the continued attraction of online learning as COVID-19 has receded, student attrition, the competitive impact from the trend of non-profit universities using online education and consolidation among our competitors. Other risks are included in our filings with the SEC including our Form 10-K for the year ended April 30, 2022. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law. About Aspen Group, Inc. Aspen Group, Inc. is an education technology holding company that leverages its infrastructure and expertise to allow its two universities, Aspen University and United States University, to deliver on the vision of making college affordable again. For more information, visit www.aspu.com . Contact Information:
日本國債管理的投資
10的投資
日本國債管理了10的投資。他們最新的投資Cascadian療法作為他們的一部分管在2011年2月2日。
日本國債管理的投資活動
日期 |
輪 |
公司 |
量 |
新的嗎? |
共同投資者 |
來源 |
---|---|---|---|---|---|---|
2/11/2011 |
管 |
Cascadian療法 |
0.15美元 |
是的 |
||
3/16/2007 |
管 |
克利夫蘭生物學實驗室 |
30.02美元 |
沒有 |
||
9/18/2006 |
管,二世 |
先進細胞技術 |
8.75美元 |
沒有 |
||
9/5/2006 |
管 |
|||||
1/19/2006 |
Unattributed VC -二世 |
日期 |
2/11/2011 |
3/16/2007 |
9/18/2006 |
9/5/2006 |
1/19/2006 |
---|---|---|---|---|---|
輪 |
管 |
管 |
管,二世 |
管 |
Unattributed VC -二世 |
公司 |
Cascadian療法 |
克利夫蘭生物學實驗室 |
先進細胞技術 |
||
量 |
0.15美元 |
30.02美元 |
8.75美元 |
||
新的嗎? |
是的 |
沒有 |
沒有 |
||
共同投資者 |
|||||
來源 |
日本國債管理投資退出
4組合退出
日本國債管理有4投資組合出口。他們最新的投資退出Cascadian療法 在2018年3月09日。
日期 |
退出 |
公司 |
估值
提交的估值公司,采自國家申請或者新聞,由VentureSource的提供,或基於比較數據的估值模型。
|
收購者 |
來源 |
---|---|---|---|---|---|
3/9/2018 |
Acq - P2P |
4 |
|||
日期 |
3/9/2018 |
|||
---|---|---|---|---|
退出 |
Acq - P2P |
|||
公司 |
||||
估值 |
||||
收購者 |
||||
來源 |
4 |